306 related articles for article (PubMed ID: 15875657)
1. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
[TBL] [Abstract][Full Text] [Related]
2. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
[TBL] [Abstract][Full Text] [Related]
3. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
Dittmer DP; Vahrson W; Staudt M; Hilscher C; Fakhari FD
AIDS Rev; 2005; 7(1):56-61. PubMed ID: 15875661
[TBL] [Abstract][Full Text] [Related]
6. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
7. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
10. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for epidemic Kaposi's sarcoma.
Aldenhoven M; Barlo NP; Sanders CJ
Int J STD AIDS; 2006 Sep; 17(9):571-8. PubMed ID: 16942647
[TBL] [Abstract][Full Text] [Related]
13. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
14. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
15. Relationship between oral Kaposi 's sarcoma and HAART: contribution of two case reports.
Campo-Trapero J; Del Romero-Guerrero J; Cano-Sánchez J; Rodríguez-Martín C; Martínez-González JM; Bascones-Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E709-13. PubMed ID: 18978711
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
17. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
[TBL] [Abstract][Full Text] [Related]
18. [HIV protease inhibitors for the treatment of Kaposi's sarcoma].
Grosso G; Sgadari C; Barillari G; Toschi E; Bacigalupo I; Carlei D; Palladino C; Baccarini S; Malavasi L; Moracci G; Leone P; Chiozzini C; Monini P; Ensoli B
Recenti Prog Med; 2003 Feb; 94(2):69-74. PubMed ID: 12908373
[TBL] [Abstract][Full Text] [Related]
19. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
20. AIDS associated Kaposi's sarcoma.
Thomas S; Sindhu CB; Sreekumar S; Sasidharan PK
J Assoc Physicians India; 2011 Jun; 59():387-9. PubMed ID: 21751599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
